BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18059400)

  • 1. Downregulation of drug transport and metabolism in mice bearing extra-hepatic malignancies.
    Sharma R; Kacevska M; London R; Clarke SJ; Liddle C; Robertson G
    Br J Cancer; 2008 Jan; 98(1):91-7. PubMed ID: 18059400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional repression of hepatic cytochrome P450 3A4 gene in the presence of cancer.
    Charles KA; Rivory LP; Brown SL; Liddle C; Clarke SJ; Robertson GR
    Clin Cancer Res; 2006 Dec; 12(24):7492-7. PubMed ID: 17189422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extra-hepatic cancer represses hepatic drug metabolism via interleukin (IL)-6 signalling.
    Kacevska M; Mahns A; Sharma R; Clarke SJ; Robertson GR; Liddle C
    Pharm Res; 2013 Sep; 30(9):2270-8. PubMed ID: 23604979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipopolysaccharide treatment downregulates the expression of the pregnane X receptor, cyp3a11 and mdr1a genes in mouse placenta.
    Chen YH; Wang JP; Wang H; Sun MF; Wei LZ; Wei W; Xu DX
    Toxicology; 2005 Aug; 211(3):242-52. PubMed ID: 15869837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversing effects of ginsenosides on LPS-induced hepatic CYP3A11/3A4 dysfunction through the pregnane X receptor.
    Sun HY; Yan YJ; Li YH; Lv L
    J Ethnopharmacol; 2019 Jan; 229():246-255. PubMed ID: 30342195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prominent impairment of liver/intestinal cytochrome P450 and intestinal drug transporters in sepsis-induced acute kidney injury over acute and chronic renal ischemia, a mouse model comparison.
    Sukkummee W; Jittisak P; Wonganan P; Wittayalertpanya S; Chariyavilaskul P; Leelahavanichkul A
    Ren Fail; 2019 Nov; 41(1):314-325. PubMed ID: 30991873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors predisposing to coma and delirium: fentanyl and midazolam exposure; CYP3A5, ABCB1, and ABCG2 genetic polymorphisms; and inflammatory factors.
    Skrobik Y; Leger C; Cossette M; Michaud V; Turgeon J
    Crit Care Med; 2013 Apr; 41(4):999-1008. PubMed ID: 23385102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daikenchuto (TU-100) alters murine hepatic and intestinal drug metabolizing enzymes in an in vivo dietary model: effects of gender and withdrawal.
    Nobutani K; Miyoshi J; Musch MW; Nishiyama M; Watanabe J; Kaneko A; Yamamoto M; Yoshida M; Kono T; Jeong H; Chang EB
    Pharmacol Res Perspect; 2017 Oct; 5(5):. PubMed ID: 28971602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor alpha (PPARalpha)-mediated regulation of multidrug resistance 2 (Mdr2) expression and function in mice.
    Kok T; Bloks VW; Wolters H; Havinga R; Jansen PL; Staels B; Kuipers F
    Biochem J; 2003 Feb; 369(Pt 3):539-47. PubMed ID: 12381268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P-Glycoprotein (MDR1/ABCB1) Restricts Brain Penetration of the Bruton's Tyrosine Kinase Inhibitor Ibrutinib, While Cytochrome P450-3A (CYP3A) Limits Its Oral Bioavailability.
    van Hoppe S; Rood JJM; Buil L; Wagenaar E; Sparidans RW; Beijnen JH; Schinkel AH
    Mol Pharm; 2018 Nov; 15(11):5124-5134. PubMed ID: 30247919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cholecystectomy on bile acids as well as relevant enzymes and transporters in mice: Implication for pharmacokinetic changes of rifampicin.
    Zhang F; Qin H; Zhao Y; Wei Y; Xi L; Rao Z; Zhang J; Ma Y; Duan Y; Wu X
    Eur J Pharm Sci; 2017 Jan; 96():141-153. PubMed ID: 27637290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased intestinal CYP3A and P-glycoprotein activities in rats with adjuvant arthritis.
    Uno S; Kawase A; Tsuji A; Tanino T; Iwaki M
    Drug Metab Pharmacokinet; 2007 Aug; 22(4):313-21. PubMed ID: 17827786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The transcription factor E4bp4 regulates the expression and activity of Cyp3a11 in mice.
    Tong Y; Zeng P; Zhang T; Zhao M; Yu P; Wu B
    Biochem Pharmacol; 2019 May; 163():215-224. PubMed ID: 30796914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased hepatic and renal expressions of multidrug resistance-associated protein 3 in Eisai hyperbilirubinuria rats.
    Kuroda M; Kobayashi Y; Tanaka Y; Itani T; Mifuji R; Araki J; Kaito M; Adachi Y
    J Gastroenterol Hepatol; 2004 Feb; 19(2):146-53. PubMed ID: 14731123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipopolysaccharide downregulates the expressions of intestinal pregnane X receptor and cytochrome P450 3a11.
    Xu DX; Wang JP; Sun MF; Chen YH; Wei W
    Eur J Pharmacol; 2006 Apr; 536(1-2):162-70. PubMed ID: 16556443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The involvement of the pregnane X receptor in hepatic gene regulation during inflammation in mice.
    Teng S; Piquette-Miller M
    J Pharmacol Exp Ther; 2005 Feb; 312(2):841-8. PubMed ID: 15456840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of CYP3A in chronic ethanol-fed mice is mediated by endogenous pregnane X receptor ligands formed by enhanced cholesterol metabolism.
    Je YT; Sim WC; Kim DG; Jung BH; Shin HS; Lee BH
    Arch Toxicol; 2015 Apr; 89(4):579-89. PubMed ID: 24853400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fasting-Induced Changes in Hepatic P450 Mediated Drug Metabolism Are Largely Independent of the Constitutive Androstane Receptor CAR.
    de Vries EM; Lammers LA; Achterbergh R; Klümpen HJ; Mathot RA; Boelen A; Romijn JA
    PLoS One; 2016; 11(7):e0159552. PubMed ID: 27434302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gestational and pregnane X receptor-mediated regulation of placental ATP-binding cassette drug transporters in mice.
    Gahir SS; Piquette-Miller M
    Drug Metab Dispos; 2011 Mar; 39(3):465-71. PubMed ID: 21127142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circadian Cyp3a11 metabolism contributes to chronotoxicity of hypaconitine in mice.
    Lin Y; Zhou Z; Yang Z; Gao L; Wang S; Yu P; Wu B
    Chem Biol Interact; 2019 Aug; 308():288-293. PubMed ID: 31150629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.